Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2019, Article ID 1243743, 10 pages
https://doi.org/10.1155/2019/1243743
Research Article

Network Pharmacology of Yougui Pill Combined with Buzhong Yiqi Decoction for the Treatment of Sexual Dysfunction

1Department of Urology, The Fifth People’s Hospital of Shanghai, Fudan University, Shanghai 200240, China
2Department of Pelvic Floor Center, Minhang District, Shanghai 200240, China

Correspondence should be addressed to Guowei Shi; nc.981@wgs.rd

Received 14 July 2019; Accepted 10 October 2019; Published 11 November 2019

Academic Editor: Wen-yi Kang

Copyright © 2019 Yangyun Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. James, “Abnormal psychology,” AJN the American Journal of Nursing, vol. 48, no. 4620, p. 219, 2014. View at Google Scholar
  2. M. P. McCabe, I. D. Sharlip, R. Lewis et al., “Risk factors for sexual dysfunction among women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015,” The Journal of Sexual Medicine, vol. 13, no. 2, pp. 153–167, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Hatzimouratidis, E. Amar, I. Eardley et al., “Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation,” European Urology, vol. 57, no. 5, pp. 804–814, 2010. View at Publisher · View at Google Scholar
  4. R. Basson, M. E. Wierman, J. Van Lankveld, and L. Brotto, “Reports: summary of the recommendations on sexual dysfunctions in women,” The Journal of Sexual Medicine, vol. 7, no. 1, pp. 314–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Rowland, C. G. Mcmahon, C. Abdo et al., “Disorders of orgasm and ejaculation in men,” Journal of Sexual Medicine, vol. 1, no. 1, pp. 58–65, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. H. A. Feldman, I. Goldstein, D. G. Hatzichristou, R. J. Krane, and J. B. Mckinlay, “Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study,” Journal of Urology, vol. 151, no. 1, pp. 54–61, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Porst, F. Montorsi, R. C. Rosen, L. Gaynor, S. Grupe, and J. Alexander, “The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking,” European Urology, vol. 51, no. 3, pp. 816–824, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. F. O. Finkelstein, S. Shirani, D. Wuerth, and S. H. Finkelstein, “Therapy insight: sexual dysfunction in patients with chronic kidney disease,” Nature Clinical Practice Nephrology, vol. 3, no. 4, pp. 200–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Chen, J. L. Shergis, L. Wu et al., “A systematic review and meta-analysis of the herbal formula Buzhong Yiqi Tang for stable chronic obstructive pulmonary disease,” Complementary Therapies in Medicine, vol. 29, pp. 94–108, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. E.-q. Li, A.-b. Zhao, K.-j. Cao, X.-y. Chen, H.-y. Dai, and X.-l. Wu, “Effects of liuwei dihuang decoction, Buzhong Yiqi decoction and compound danshen decoction on the marrow-suppressed mice,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 5, 2010. View at Google Scholar
  11. L. Hongzhu, Treatment of Impotence from Qi Deficiency and its Clinical Study, Traditional Chinese Medicine University of Guangzhou, Guangzhou, China, 2016.
  12. W. Jianjun, “Treatment of 50 cases of male sexual dysfunction with Guipi decoction and Yougui Pill,” The Latest Medical Information Abstracts in the World, vol. 13, 146 pages, 2015. View at Google Scholar
  13. Z. Jinxiang, “Observation on the curative effect of Yougui Pill in the treatment of penile erectile dysfunction,” in Proceedings of the National Conference on Male Medicine of Integrated Traditional Chinese and Western Medicine, 2005.
  14. J.-H. Pan, “New paradigm for drug discovery based on network pharmacology,” Chinese Journal of New Drugs and Clinical Remedies, vol. 28, pp. 721–726, 2009. View at Google Scholar
  15. Z. Gui-Biao, L. Qing-Ya, C. Qi-Long, and S. Shi-Bing, “Network pharmacology: a new approach for Chinese herbal medicine research,” Evidence-Based Complementray and Alternative Medicine, vol. 2013, no. 8, Article ID 621423, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Li, B. Zhang, D. Jiang, Y. Wei, and N. Zhang, “Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae,” BMC Bioinformatics, vol. 11, no. 11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Zhao, L. Guochun, Y. Yang, L. Shi, L. Xu, and L. Yin, “A network pharmacology approach to determine active ingredients and rationality of herb combinations of modified-Simiaowan for treatment of gout,” Journal of Ethnopharmacology, vol. 168, pp. 1–16, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Ru, L. Peng, J. Wang et al., “TCMSP: a database of systems pharmacology for drug discovery from herbal medicines,” Journal of Cheminformatics, vol. 6, no. 1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. C. Madden, “In silico approaches for predicting Adme properties,” in Challenges and Advances in Computational Chemistry and Physics, Springer, Berlin, Germany, 2010. View at Publisher · View at Google Scholar
  20. P. Ertl, B. Rohde, and P. Selzer, “Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties,” Journal of Medicinal Chemistry, vol. 43, no. 20, pp. 3714–3717, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Liu, F. Guo, Y. Wang et al., “BATMAN-TCM: a bioinformatics analysis tool for molecular mechanism of traditional Chinese medicine,” Scientific Reports, vol. 6, no. 1, 21146 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Allan Peter, B. L. King, M. Susan et al., “The comparative toxicogenomics database: update 2011,” Nucleic Acids Research, vol. 41, no. 1, pp. D1104–D1114, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. A.-L. Barabási and R. Albert, “Emergence of scaling in random networks,” Science, vol. 286, no. 5439, pp. 509–512, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Hua and L. Shoudan, “Local network topology in human protein interaction data predicts functional association,” PLos One, vol. 4, no. 7, e6410 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Bindea, B. Mlecnik, H. Hackl et al., “ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks,” Bioinformatics, vol. 25, no. 8, pp. 1091–1093, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. W. H. Da, B. T. Sherman, Q. Tan et al., “The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists,” Genome Biology, vol. 8, no. 9, R183 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Damian, F. Andrea, W. Stefan et al., “STRING v10: protein-protein interaction networks, integrated over the tree of life,” Nucleic Acids Research, vol. 43, no. D1, pp. D447–D452, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Zhang, X. Wang, and S. Li, “An integrative platform of TCM network pharmacology and its application on a herbal formula, qing-Luo-yin,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 456747, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Zhang, Y. Wang, Z. Yang et al., “Antioxidant treatment with quercetin ameliorates erectile dysfunction in streptozotocin-induced diabetic rats,” Journal of Bioscience and Bioengineering, vol. 112, no. 3, pp. 215–218, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Zhang, C. Huang, S. Liu et al., “Effects of quercetin on intracavernous pressure and expression of nitrogen synthase isoforms in arterial erectile dysfunction rat model,” International Journal of Clinical & Experimental Medicine, vol. 8, no. 5, p. 7599, 2015. View at Google Scholar
  31. T.-C. Kao, M.-H. Shyu, and G.-C. Yen, “Glycyrrhizic acid and 18β-glycyrrhetinic acid inhibit inflammation via PI3K/Akt/GSK3β signaling and glucocorticoid receptor activation,” Journal of Agricultural and Food Chemistry, vol. 58, no. 15, pp. 8623–8629, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. F. C. Fachini-Queiroz, R. Kummer, C. F. Estevao-Silva et al., “Effects of thymol and carvacrol, constituents of thymus vulgaris L. essential oil, on the inflammatory response,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 657026, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. M. Ha, M. Y. Kim, M. K. Park et al., “Higenamine reduces HMGB1 during hypoxia-induced brain injury by induction of heme oxygenase-1 through PI3K/Akt/Nrf-2 signal pathways,” Apoptosis, vol. 17, no. 5, pp. 463–474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. M. De Mieri, M. Kaiser, R. Brun, U. Thormann, G. Imanidis, and M. Hamburger, “Anti-trypanosomal cadinanes synthesized by transannular cyclization of the natural sesquiterpene lactone nobilin,” Bioorganic & Medicinal Chemistry, vol. 23, no. 7, pp. 1521–1529, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. A. O. Antwi, D. D. Obiri, and N. Osafo, “Stigmasterol modulates allergic airway inflammation in Guinea pig model of ovalbumin-induced asthma,” Mediators of Inflammation, vol. 2017, Article ID 2953930, 11 pages, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. W. V. Berghe, K. De Bosscher, S. Van Calenbergh, G. Haegeman, and C. J. Lacey, “Synephrine derivatives useful as anti-inflammatory agents,” 2011, Google Patents CA-2634359A1. View at Google Scholar
  37. C. Vlachopoulos, K. Rokkas, N. Ioakeimidis, and C. Stefanadis, “Inflammation, metabolic syndrome, erectile dysfunction, and coronary artery disease: common links,” European Urology, vol. 52, no. 6, pp. 1590–1600, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. A. K. Farrell, R. B. Slatcher, E. T. Tobin et al., “Socioeconomic status, family negative emotional climate, and anti-inflammatory gene expression among youth with asthma,” Psychoneuroendocrinology, vol. 91, pp. 62–67, 2018. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Shi, Z. Shi, H. Huang et al., “Ability of recombinant human catalase to suppress inflammation of the murine lung induced by influenza A,” Inflammation, vol. 37, no. 3, pp. 809–817, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. M. D. Howard, C. F. Greineder, E. D. Hood, and V. R. Muzykantov, “Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation,” Journal of Controlled Release, vol. 177, pp. 34–41, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. S. W. Ham, H.-Y. Jeon, X. Jin et al., “TP53 gain-of-function mutation promotes inflammation in glioblastoma,” Cell Death & Differentiation, vol. 26, no. 3, pp. 409–425, 2019. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Vignozzi, S. Filippi, P. Comeglio et al., “Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit,” The Journal of Sexual Medicine, vol. 11, no. 12, pp. 2890–2902, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. P. Schramek and M. Waldhauser, “Dose-dependent effect and side-effect of prostaglandin E1 in erectile dysfunction,” British Journal of Clinical Pharmacology, vol. 28, no. 5, pp. 567–571, 1989. View at Publisher · View at Google Scholar · View at Scopus
  44. C. Vlachopoulos, K. Aznaouridis, N. Ioakeimidis et al., “Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease,” European Heart Journal, vol. 27, no. 22, pp. 2640–2648, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. G. I. Russo, S. Cimino, E. Fragalà et al., “Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study,” The Journal of Sexual Medicine, vol. 11, no. 8, pp. 2074–2082, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Shirai, M. Yamanaka, H. Shiina et al., “Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatment,” Urology, vol. 64, no. 6, pp. 1244–1249, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. E. K. Kim and E. J. Choi, “Pathological roles of MAPK signaling pathways in human diseases,” Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, vol. 1802, no. 4, pp. 396–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Miles, B. Candy, L. Jones, R. Williams, A. Tookman, and M. King, “Interventions for sexual dysfunction following treatments for cancer,” Cochrane Database of Systematic Reviews, vol. 17, no. 4, 2007. View at Google Scholar
  49. W. D. Steers, “Pharmacologic treatment of erectile dysfunction,” Reviews in Urology, vol. 4, no. 3, S17 pages, 2002. View at Google Scholar
  50. F. Giuliano and J. Allard, “Dopamine and male sexual function,” European Urology, vol. 40, no. 6, pp. 601–608, 2001. View at Publisher · View at Google Scholar · View at Scopus